Ipca Laboratories consolidated net profit rises 58.20% in the September 2024 quarter
Sales rise 15.78% to Rs 2354.90 crore
Net profit of Ipca Laboratories rose 58.20% to Rs 229.48 crore in the quarter ended September 2024 as against Rs 145.06 crore during the previous quarter ended September 2023. Sales rose 15.78% to Rs 2354.90 crore in the quarter ended September 2024 as against Rs 2033.96 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales2354.902033.96 16 OPM %18.7517.73 -PBDT445.18354.99 25 PBT344.83264.65 30 NP229.48145.06 58Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 14 2024 | 2:12 PM IST